Wordt geladen...
A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data
In several neurodegenerative diseases, like Huntington's disease (HD), treatments are still lacking. To determine whether a treatment is effective, sensitive disease progression biomarkers are especially needed for the premanifest phase, since this allows the evaluation of neuroprotective treat...
Bewaard in:
Hoofdauteurs: | , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Nature Publishing Group
2013
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3647202/ https://ncbi.nlm.nih.gov/pubmed/23652721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep01797 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|